CHANTEL HAYDEN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NEW YORK, NY NPI 1932829355

General Payments — all program years on this page

$825.78

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 16
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $794.17 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Long term medical supply or device loan $681.537
Food and Beverage $112.647

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $763.5813
EMD Serono, Inc. $30.591

By program year

Program yearAmountRecords
2023 $31.612
2024 $794.1714

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086929681 Novartis Pharmaceuticals Corporation $17.93 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086929683 Novartis Pharmaceuticals Corporation $26.32 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086929685 Novartis Pharmaceuticals Corporation $1.26 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086929687 Novartis Pharmaceuticals Corporation $10.86 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086929689 Novartis Pharmaceuticals Corporation $7.03 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086929691 Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086929693 Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086929695 Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086929697 Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086929699 Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086929701 Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086929703 Novartis Pharmaceuticals Corporation $83.33 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086929705 Novartis Pharmaceuticals Corporation $18.65 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120226679 EMD Serono, Inc. $30.59 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.